Non-Small Cell Adenocarcinoma
specificA carcinoma characterized by the presence of large adenocarcinoma cells.
14
Centers
9
Active Trials
—
Cancer Funding
Top Centers for Non-Small Cell Adenocarcinoma(14)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 61.6 |
| 2 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive Active Research Program | 61.6 |
| 3 | Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive Active Research Program | 61.6 |
| 4 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program | 61.6 |
| 5 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive Active Research Program | 61.6 |
| 6 | University of Illinois Cancer CenterChicago, IL Active Research Program | 61.6 |
| 7 | Boston University Cancer CenterBoston, MA Active Research Program | 61.6 |
| 8 | Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL Active Research Program | 61.6 |
| 9 | Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ Active Research Program | 61.6 |
| 10 | UPMC Hillman Cancer CenterPittsburgh, PA NCI Comprehensive | 39.1 |
| 11 | Vanderbilt-Ingram Cancer CenterNashville, TN NCI Comprehensive | 39.1 |
| 12 | OHSU Knight Cancer InstitutePortland, OR NCI Comprehensive | 39.1 |
| 13 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive | 39.1 |
| 14 | Princess Margaret Cancer CentreToronto, ON | 39.1 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →